ARTICLE | Clinical News
Veletri epoprostenol regulatory update
October 11, 2010 7:00 AM UTC
FDA approved additional conditions for preparation and storage of Veletri epoprostenol to treat moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectru...